{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:08:20Z","timestamp":1774264100073,"version":"3.50.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T00:00:00Z","timestamp":1459728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s11910-016-0643-8","type":"journal-article","created":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T08:05:41Z","timestamp":1459757141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["New Genetic Approaches to AD: Lessons from APOE-TOMM40 Phylogenetics"],"prefix":"10.1007","volume":"16","author":[{"given":"Michael W.","family":"Lutz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Crenshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen A.","family":"Welsh-Bohmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel K.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen D.","family":"Roses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,4]]},"reference":[{"issue":"4","key":"643_CR1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/alzrt269","volume":"6","author":"JL Cummings","year":"2014","unstructured":"Cummings JL, Morstorf T, Zhong K. Alzheimer\u2019s disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res Ther. 2014;6(4):37.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"643_CR2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jalz.2010.11.005","volume":"7","author":"R Mayeux","year":"2011","unstructured":"Mayeux R et al. Operationalizing diagnostic criteria for Alzheimer\u2019s disease and other age-related cognitive impairment-Part 1. Alzheimers Dement. 2011;7(1):15\u201334.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"643_CR3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):270\u20139.","journal-title":"Alzheimers Dement"},{"key":"643_CR4","doi-asserted-by":"crossref","unstructured":"Reiman, E.M., et al. CAP-advancing the evaluation of preclinical Alzheimer disease treatments. Nat Rev Neurol. 2016;12(1):56\u201361.","DOI":"10.1038\/nrneurol.2015.177"},{"issue":"6","key":"643_CR5","first-page":"1034","volume":"48","author":"MA Pericak-Vance","year":"1991","unstructured":"Pericak-Vance MA et al. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet. 1991;48(6):1034\u201350.","journal-title":"Am J Hum Genet"},{"issue":"5123","key":"643_CR6","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder EH et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science. 1993;261(5123):921\u20133.","journal-title":"Science"},{"key":"643_CR7","doi-asserted-by":"crossref","unstructured":"Liu N et al.\u00a0Haplotype-Association Analysis. Adv Genet. 2008;60:335\u2013405.","DOI":"10.1016\/S0065-2660(07)00414-2"},{"issue":"20","key":"643_CR8","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"DE Schmechel","year":"1993","unstructured":"Schmechel DE et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci. 1993;90(20):9649\u201353.","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"643_CR9","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders AM et al. Association of apolipoprotein E allele \u03b54 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology. 1993;43(8):1467\u201372.","journal-title":"Neurology"},{"issue":"2","key":"643_CR10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/nan.12101","volume":"40","author":"C Medway","year":"2014","unstructured":"Medway C, Morgan K. Review: the genetics of Alzheimer\u2019s disease; putting flesh on the bones. Neuropathol Appl Neurobiol. 2014;40(2):97\u2013105.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"12","key":"643_CR11","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"J-C Lambert","year":"2013","unstructured":"Lambert J-C et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45(12):1452\u20138.","journal-title":"Nat Genet"},{"key":"643_CR12","doi-asserted-by":"crossref","unstructured":"Chouraki, V. and S. Seshadri, Genetics of Alzheimer\u2019s disease. Adv Genet, 2014. 87: p. 245-94. This is a comprehensive review of the genetics of Alzheimer\u2019s Disease that includes relevant discussion about structural variants, rare variants, untangling the genetics of the APOE-TOMM40 region and gene-environment interactions. Translational genetics are addressed with emphasis on using genetics for risk prediction and for identification of new drug targets.","DOI":"10.1016\/B978-0-12-800149-3.00005-6"},{"key":"643_CR13","doi-asserted-by":"crossref","unstructured":"Hollingworth P et al. Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet. 2011;43(5):429-35.","DOI":"10.1038\/ng.803"},{"issue":"17","key":"643_CR14","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMp0806284","volume":"360","author":"DB Goldstein","year":"2009","unstructured":"Goldstein DB. Common genetic variation and human traits. N Engl J Med. 2009;360(17):1696\u20138.","journal-title":"N Engl J Med"},{"issue":"11","key":"643_CR15","doi-asserted-by":"crossref","first-page":"e79771","DOI":"10.1371\/journal.pone.0079771","volume":"8","author":"PG Ridge","year":"2013","unstructured":"Ridge PG et al. Alzheimer\u2019s disease: analyzing the missing heritability. PLoS One. 2013;8(11):e79771.","journal-title":"PLoS One"},{"issue":"2","key":"643_CR16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz M et al. Role of Genes and Environments for Explaining Alzheimer Disease. Arch Gen Psychiatry. 2006;63(2):168\u201374.","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"643_CR17","first-page":"S480","volume":"7","author":"A Stefano De","year":"2011","unstructured":"De Stefano A, S.S, Fitzpatrick A, Ikram M, Gudnason V, Boada M, et al. Genome-wide association studies using prospective cohorts: the CHARGE consortium. Alzheimers Dement. 2011;7(4):S480.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"643_CR18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet. 2009;41(10):1088\u201393.","journal-title":"Nat Genet"},{"issue":"7497","key":"643_CR19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature13127","volume":"508","author":"DG MacArthur","year":"2014","unstructured":"MacArthur DG et al. Guidelines for investigating causality of sequence variants in human disease. Nature. 2014;508(7497):469\u201376.","journal-title":"Nature"},{"issue":"3","key":"643_CR20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ajhg.2012.07.010","volume":"91","author":"Q Zhu","year":"2012","unstructured":"Zhu Q et al. Prioritizing genetic variants for causality on the basis of preferential linkage disequilibrium. Am J Hum Genet. 2012;91(3):422\u201334.","journal-title":"Am J Hum Genet"},{"key":"643_CR21","doi-asserted-by":"crossref","unstructured":"Bochdanovits Z et al. Accurate prediction of a minimal region around a genetic association signal that contains the causal variant. Eur J Hum Genet. 2014;22(2):238\u201342.","DOI":"10.1038\/ejhg.2013.115"},{"issue":"7","key":"643_CR22","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/gepi.20522","volume":"34","author":"YY Teo","year":"2010","unstructured":"Teo YY et al. Identifying candidate causal variants via trans-population fine-mapping. Genet Epidemiol. 2010;34(7):653\u201364.","journal-title":"Genet Epidemiol"},{"issue":"Pt 5","key":"643_CR23","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1469-1809.2009.00536.x","volume":"73","author":"Y Liu","year":"2009","unstructured":"Liu Y et al. A regression-based association test for case-control studies that uses inferred ancestral haplotype similarity. Ann Hum Genet. 2009;73(Pt 5):520\u20136.","journal-title":"Ann Hum Genet"},{"issue":"5","key":"643_CR24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/tpj.2009.69","volume":"10","author":"AD Roses","year":"2010","unstructured":"Roses AD et al. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer\u2019s disease. Pharmacogenomics J. 2010;10(5):375\u201384.","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"643_CR25","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1681\/ASN.2005050465","volume":"17","author":"Y Liu","year":"2006","unstructured":"Liu Y et al. IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol. 2006;17(3):863\u201370.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"643_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ana.24305","volume":"77","author":"BN Vardarajan","year":"2015","unstructured":"Vardarajan BN et al. Coding mutations in SORL1 and Alzheimer disease. Ann Neurol. 2015;77(2):215\u201327.","journal-title":"Ann Neurol"},{"issue":"Suppl","key":"643_CR27","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1194\/jlr.R800069-JLR200","volume":"50","author":"RW Mahley","year":"2009","unstructured":"Mahley RW, Weisgraber KH, Huang Y. Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer\u2019s disease to AIDS. J Lipid Res. 2009;50(Suppl):S183\u20138.","journal-title":"J Lipid Res"},{"key":"643_CR28","first-page":"3","volume":"2","author":"DM Holtzman","year":"2012","unstructured":"Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2:3.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"643_CR29","doi-asserted-by":"crossref","unstructured":"Linnertz C, A.L., Gottschalk W, Crenshaw D, Lutz MW, Allen J, Saith S, Mihovilovic M, Burke JR, Welsh-Bohmer KA, Roses AD, Chiba-Falek O, The cis-regulatory effect of an Alzheimer\u2019s disease-associated poly-T locus on expression of TOMM40 and APOE genes. Alzheimers & Dement. 2014;10(5):541\u201351.","DOI":"10.1016\/j.jalz.2013.08.280"},{"issue":"3","key":"643_CR30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1212\/WNL.0b013e3182605801","volume":"79","author":"M Allen","year":"2012","unstructured":"Allen M et al. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology. 2012;79(3):221\u20138.","journal-title":"Neurology"},{"key":"643_CR31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.coph.2013.12.002","volume":"14","author":"AD Roses","year":"2014","unstructured":"Roses AD et al. New applications of disease genetics and pharmacogenetics to drug development. Curr Opin Pharmacol. 2014;14:81\u20139.","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"643_CR32","doi-asserted-by":"crossref","first-page":"e31039","DOI":"10.1371\/journal.pone.0031039","volume":"7","author":"C Cruchaga","year":"2012","unstructured":"Cruchaga C et al. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer\u2019s disease families. PLoS One. 2012;7(2):e31039.","journal-title":"PLoS One"},{"issue":"12","key":"643_CR33","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1016\/j.neurobiolaging.2014.06.002","volume":"35","author":"C Sassi","year":"2014","unstructured":"Sassi C et al. Investigating the role of rare coding variability in Mendelian dementia genes (APP, PSEN1, PSEN2, GRN, MAPT, and PRNP) in late-onset Alzheimer\u2019s disease. Neurobiol Aging. 2014;35(12):2881. e1-6.","journal-title":"Neurobiol Aging"},{"issue":"7409","key":"643_CR34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T et al. A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature. 2012;488(7409):96\u20139.","journal-title":"Nature"},{"key":"643_CR35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1326-9-11","volume":"9","author":"CW Medway","year":"2014","unstructured":"Medway CW et al. ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer\u2019s disease. Mol Neurodegener. 2014;9:11.","journal-title":"Mol Neurodegener"},{"key":"643_CR36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fgene.2014.00369","volume":"5","author":"J Lord","year":"2014","unstructured":"Lord J, Lu AJ, Cruchaga C. Identification of rare variants in Alzheimer\u2019s disease. Front Genet. 2014;5:369.","journal-title":"Front Genet"},{"issue":"11","key":"643_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-014-0499-8","volume":"14","author":"J Ringman","year":"2014","unstructured":"Ringman J et al. Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies. Curr Neurol Neurosci Rep. 2014;14(11):1\u20139. This study advanced the idea that AD is heterogeneous and that different genetic subtypes of the disease may not uniformly respond to a given intervention. Examples from the recently failed AD therapeutic trials are shared to illustrate the importance of considering biologic pathway differences associated with different genetic origins when designing clinical trials.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"7","key":"643_CR38","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jalz.2015.05.004","volume":"11","author":"LA Beckett","year":"2015","unstructured":"Beckett LA et al. The Alzheimer\u2019s disease neuroimaging initiative phase 2: increasing the length, breadth, and depth of our understanding. Alzheimers Dement. 2015;11(7):823\u201331.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"643_CR39","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jalz.2013.09.003","volume":"10","author":"J Nettiksimmons","year":"2014","unstructured":"Nettiksimmons J et al. Biological heterogeneity in ADNI amnestic mild cognitive impairment. Alzheimers Dement. 2014;10(5):511\u201321. e1.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"643_CR40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00439-008-0568-7","volume":"124","author":"S Browning","year":"2008","unstructured":"Browning S. Missing data imputation and haplotype phase inference for genome-wide association studies. Hum Genet. 2008;124(5):439\u201350.","journal-title":"Hum Genet"},{"issue":"4","key":"643_CR41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/gepi.20037","volume":"27","author":"DJ Schaid","year":"2004","unstructured":"Schaid DJ. Evaluating associations of haplotypes with traits. Genet Epidemiol. 2004;27(4):348\u201364.","journal-title":"Genet Epidemiol"},{"issue":"1","key":"643_CR42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1517\/14622416.2.1.11","volume":"2","author":"JS Bader","year":"2001","unstructured":"Bader JS. The relative power of SNPs and haplotype as genetic markers for association tests. Pharmacogenomics. 2001;2(1):11\u201324.","journal-title":"Pharmacogenomics"},{"issue":"4","key":"643_CR43","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.ejhg.5200619","volume":"9","author":"J Akey","year":"2001","unstructured":"Akey J, Jin L, Xiong M. Haplotypes vs single marker linkage disequilibrium tests: what do we gain? Eur J Hum Genet. 2001;9(4):291\u2013300.","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"643_CR44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/gepi.10200","volume":"23","author":"RW Morris","year":"2002","unstructured":"Morris RW, Kaplan NL. On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol. 2002;23(3):221\u201333.","journal-title":"Genet Epidemiol"},{"issue":"37","key":"643_CR45","doi-asserted-by":"crossref","first-page":"14747","DOI":"10.1073\/pnas.0706645104","volume":"104","author":"JV Raelson","year":"2007","unstructured":"Raelson JV et al. Genome-wide association study for Crohn\u2019s disease in the Quebec Founder Population identifies multiple validated disease loci. Proc Natl Acad Sci U S A. 2007;104(37):14747\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"643_CR46","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/hmg\/ddg243","volume":"12","author":"JH Lee","year":"2003","unstructured":"Lee JH et al. A haplotype-based molecular analysis of CFTR mutations associated with respiratory and pancreatic diseases. Hum Mol Genet. 2003;12(18):2321\u201332.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"643_CR47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ajmg.b.30993","volume":"153B","author":"LM Bekris","year":"2010","unstructured":"Bekris LM et al. APOE mRNA and protein expression in postmortem brain are modulated by an extended haplotype structure. Am J Med Genet Part B. 2010;153B(2):409\u201317.","journal-title":"Am J Med Genet Part B"},{"issue":"7","key":"643_CR48","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.neurobiolaging.2007.10.013","volume":"30","author":"EK Tan","year":"2009","unstructured":"Tan EK et al. SORL1 haplotypes modulate risk of Alzheimer\u2019s disease in Chinese. Neurobiol Aging. 2009;30(7):1048\u201351.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"643_CR49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1001\/archneurol.2010.346","volume":"68","author":"C Reitz","year":"2011","unstructured":"Reitz C et al. Meta-analysis of the association between variants in SORL1 and Alzheimer disease. Arch Neurol. 2011;68(1):99\u2013106.","journal-title":"Arch Neurol"},{"issue":"2","key":"643_CR50","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/genetics\/132.2.619","volume":"132","author":"AR Templeton","year":"1992","unstructured":"Templeton AR, Crandall KA, Sing CF. A Cladistic Analysis of Phenotypic Associations With Haplotypes Inferred From Restriction Endonuclease Mapping and DNA Sequence Data, III Cladogram Estimation. Genetics. 1992;132(2):619\u201333.","journal-title":"Genetics"},{"issue":"1","key":"643_CR51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/biostatistics\/kxj030","volume":"8","author":"TG Clark","year":"2007","unstructured":"Clark TG, De Iorio M, Griffiths RC. Bayesian logistic regression using a perfect phylogeny. Biostatistics. 2007;8(1):32\u201352.","journal-title":"Biostatistics"},{"issue":"5","key":"643_CR52","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1086\/508901","volume":"79","author":"MJ Minichiello","year":"2006","unstructured":"Minichiello MJ, Durbin R. Mapping trait loci by use of inferred ancestral recombination graphs. Am J Hum Genet. 2006;79(5):910\u201322.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"643_CR53","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1086\/339271","volume":"70","author":"AP Morris","year":"2002","unstructured":"Morris AP, Whittaker JC, Balding DJ. Fine-scale mapping of disease loci via shattered coalescent modeling of genealogies. AmJ Hum Genet. 2002;70(3):686\u2013707.","journal-title":"AmJ Hum Genet"},{"issue":"2","key":"643_CR54","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1534\/genetics.104.031799","volume":"169","author":"S Z\u00f6llner","year":"2005","unstructured":"Z\u00f6llner S, Pritchard JK. Coalescent-based association mapping and fine mapping of complex trait loci. Genetics. 2005;169(2):1071\u201392.","journal-title":"Genetics"},{"issue":"1","key":"643_CR55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2156-6-24","volume":"6","author":"C Bardel","year":"2005","unstructured":"Bardel C et al. On the use of haplotype phylogeny to detect disease susceptibility loci. BMC Genet. 2005;6(1):24\u201337.","journal-title":"BMC Genet"},{"issue":"19","key":"643_CR56","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/bioinformatics\/btn406","volume":"24","author":"ZH Ding","year":"2008","unstructured":"Ding ZH, Mailund T, Song YS. Efficient whole-genome association mapping using local phylogenies for unphased genotype data. Bioinformatics. 2008;24(19):2215\u201321.","journal-title":"Bioinformatics"},{"issue":"1","key":"643_CR57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/422174","volume":"75","author":"C Durrant","year":"2004","unstructured":"Durrant C et al. Linkage disequilibrium mapping via cladistic analysis of single-nucleotide polymorphism haplotypes. Am J Hum Genet. 2004;75(1):35\u201343.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"643_CR58","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1371\/journal.pgen.0030046","volume":"3","author":"J Liu","year":"2007","unstructured":"Liu J, Papasian C, Deng HW. Incorporating single-locus tests into haplotype cladistic analysis in case-control studies. PLoS Genet. 2007;3(3):e46.","journal-title":"PLoS Genet"},{"key":"643_CR59","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2105-7-22","volume":"7","author":"T Mailund","year":"2006","unstructured":"Mailund T, Besenbacher S, Schierup MH. Whole genome association mapping by incompatibilities and local perfect phylogenies. BMC Bioinformatics. 2006;7:22.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"643_CR60","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/gepi.10246","volume":"25","author":"H Seltman","year":"2003","unstructured":"Seltman H, Roeder K, Devlin B. Evolutionary-based association analysis using haplotype data. Genet Epidemiol. 2003;25(1):48\u201358.","journal-title":"Genet Epidemiol"},{"issue":"2","key":"643_CR61","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1109\/TCBB.2006.28","volume":"3","author":"P Sevon","year":"2006","unstructured":"Sevon P, Toivonen H, Ollikainen V. TreeDT: tree pattern mining for gene mapping. IEEE\/ACM Trans Comput Biol Bioinform. 2006;3(2):174\u201385.","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"issue":"7","key":"643_CR62","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/bioinformatics\/btn071","volume":"24","author":"SY Su","year":"2008","unstructured":"Su SY, Balding DJ, Coin LJ. Disease association tests by inferring ancestral haplotypes using a hidden markov model. Bioinformatics. 2008;24(7):972\u20138.","journal-title":"Bioinformatics"},{"issue":"7","key":"643_CR63","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1371\/journal.pgen.0030111","volume":"3","author":"I Tachmazidou","year":"2007","unstructured":"Tachmazidou I, Verzilli C, Iorio M. Genetic association mapping via evolution-based clustering of haplotypes. PLoS Genet. 2007;3(7):e111.","journal-title":"PLoS Genet"},{"issue":"1-3","key":"643_CR64","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000073730","volume":"56","author":"DC Thomas","year":"2003","unstructured":"Thomas DC et al. Bayesian spatial modeling of haplotype associations. Hum Hered. 2003;56(1-3):32\u201340.","journal-title":"Hum Hered"},{"issue":"3","key":"643_CR65","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/gepi.20063","volume":"28","author":"JY Tzeng","year":"2005","unstructured":"Tzeng JY. Evolutionary-based grouping of haplotypes in association analysis. Genet Epidemiol. 2005;28(3):220\u201331.","journal-title":"Genet Epidemiol"},{"issue":"2","key":"643_CR66","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/gepi.20134","volume":"30","author":"ER Waldron","year":"2006","unstructured":"Waldron ER, Whittaker JC, Balding DJ. Fine mapping of disease genes via haplotype clustering. Genet Epidemiol. 2006;30(2):170\u20139.","journal-title":"Genet Epidemiol"},{"issue":"1","key":"643_CR67","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/ijms11010124","volume":"11","author":"AR Templeton","year":"2010","unstructured":"Templeton AR. The diverse applications of cladistic analysis of molecular evolution, with special reference to nested clade analysis. Int J Mol Sci. 2010;11(1):124\u201339. Templeton describes the application of evolutionary genealogy of DNA lineages, including intraspecific studies, for genotype\/phenotype associations at candidate loci and in genome-wide association studies. The author also establishes the theoretical framework of using phylogenetic analysis to untangle a region of high linkage disequilibrium for a genotype\/phenotype association study.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"643_CR68","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00439-008-0472-1","volume":"123","author":"BL Browning","year":"2008","unstructured":"Browning BL, Browning SR. Haplotypic analysis of Wellcome Trust Case Control Consortium data. Hum Genet. 2008;123(3):273\u201380.","journal-title":"Hum Genet"},{"key":"643_CR69","doi-asserted-by":"crossref","unstructured":"Browning, S.R. and B.L. Browning, Haplotype phasing: existing methods and new developments. Nat Rev Genet. 2011;12(10):703\u201314","DOI":"10.1038\/nrg3054"},{"issue":"2","key":"643_CR70","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/clpt.2012.222","volume":"93","author":"DG Crenshaw","year":"2013","unstructured":"Crenshaw DG et al. Using genetics to enable studies on the prevention of Alzheimer\u2019s disease. Clin Pharmacol Ther. 2013;93(2):177\u201385. This paper presented the use of a composite genetic biomarker to stratify for disease risk in clinical studies aimed at delaying or preventing the onset of AD in individuals at high risk.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"643_CR71","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jalz.2012.10.009","volume":"9","author":"AD Roses","year":"2013","unstructured":"Roses AD et al. TOMM40 and APOE: requirements for replication studies of association with age of disease onset and enrichment of a clinical trial. Alzheimers Dement. 2013;9(2):132\u20136.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"643_CR72","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jalz.2010.11.012","volume":"7","author":"SC Johnson","year":"2011","unstructured":"Johnson SC et al. The effect of TOMM40 poly-T length on gray matter volume and cognition in middle-aged persons with APOE \u025b3\/\u025b3 genotype. Alzheimer\u2019s Dementia. 2011;7(4):456\u201365.","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"5","key":"643_CR73","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jalz.2011.10.005","volume":"8","author":"KM Hayden","year":"2012","unstructured":"Hayden KM et al. A homopolymer polymorphism in the TOMM40 gene contributes to cognitive performance in aging. Alzheimers Dement. 2012;8(5):381\u20138.","journal-title":"Alzheimers Dement"},{"key":"643_CR74","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/gbe\/evq077","volume":"3","author":"DH Huson","year":"2011","unstructured":"Huson DH, Scornavacca C. A survey of combinatorial methods for phylogenetic networks. Genome Biol Evol. 2011;3:23\u201335.","journal-title":"Genome Biol Evol"},{"issue":"3","key":"643_CR75","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrg2950","volume":"12","author":"R Tewhey","year":"2011","unstructured":"Tewhey R et al. The importance of phase information for human genomics. Nat Rev Genet. 2011;12(3):215\u201323.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"643_CR76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000294","volume":"8","author":"SP Dickson","year":"2010","unstructured":"Dickson SP et al. Rare variants create synthetic genome-wide associations. PLoS Biol. 2010;8(1), e1000294.","journal-title":"PLoS Biol"},{"key":"643_CR77","doi-asserted-by":"crossref","unstructured":"Lescai, F., et al., An APOE haplotype associated with decreased epsilon4 expression increases the risk of late onset Alzheimer\u2019s disease. J Alzheimers Dis. 2011;24(2):235\u201345.","DOI":"10.3233\/JAD-2011-101764"},{"issue":"6","key":"643_CR78","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jama.285.6.739","volume":"285","author":"HC Hendrie","year":"2001","unstructured":"Hendrie HC et al. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA. 2001;285(6):739\u201347.","journal-title":"JAMA"},{"issue":"10","key":"643_CR79","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1176\/ajp.152.10.1485","volume":"152","author":"HC Hendrie","year":"1995","unstructured":"Hendrie HC et al. Prevalence of Alzheimer\u2019s disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry. 1995;152(10):1485\u201392.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"643_CR80","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jalz.2009.01.026","volume":"5","author":"KS Hall","year":"2009","unstructured":"Hall KS et al. Prevalence rates for dementia and Alzheimer\u2019s disease in African Americans: 1992 versus 2001. Alzheimers Dement. 2009;5(3):227\u201333.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"643_CR81","first-page":"574","volume":"58","author":"MX Tang","year":"1996","unstructured":"Tang MX et al. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet. 1996;58(3):574\u201384.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"643_CR82","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1212\/WNL.56.1.49","volume":"56","author":"MX Tang","year":"2001","unstructured":"Tang MX et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology. 2001;56(1):49\u201356.","journal-title":"Neurology"},{"issue":"6","key":"643_CR83","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jalz.2014.06.009","volume":"10","author":"AD Roses","year":"2014","unstructured":"Roses AD et al. African-American TOMM40\u2019523-APOE haplotypes are admixture of West African and Caucasian alleles. Alzheimers Dement. 2014;10(6):592\u2013601. e2.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"643_CR84","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/jhg.2011.123","volume":"57","author":"LM Bekris","year":"2012","unstructured":"Bekris LM, Lutz F, Yu C-E. Functional analysis of APOE locus genetic variation implicates regional enhancers in the regulation of both TOMM40 and APOE. J Hum Genet. 2012;57(1):18\u201325.","journal-title":"J Hum Genet"},{"issue":"10","key":"643_CR85","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/archneurol.2012.2052","volume":"69","author":"G Jun","year":"2012","unstructured":"Jun G et al. Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. Arch Neurol. 2012;69(10):1270\u20139.","journal-title":"Arch Neurol"},{"issue":"8","key":"643_CR86","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1001\/archneurol.2011.155","volume":"68","author":"C Cruchaga","year":"2011","unstructured":"Cruchaga C et al. Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. Arch Neurol. 2011;68(8):1013\u20139.","journal-title":"Arch Neurol"},{"issue":"5","key":"643_CR87","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jalz.2012.06.009","volume":"9","author":"G Li","year":"2013","unstructured":"Li G et al. TOMM40 intron 6 poly-T length, age at onset, and neuropathology of AD in individuals with APOE epsilon3\/epsilon3. Alzheimers Dement. 2013;9(5):554\u201361.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"643_CR88","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0378-1119(99)00380-7","volume":"239","author":"J Akai","year":"1999","unstructured":"Akai J, Kimura A, Hata RI. Transcriptional regulation of the human type I collagen alpha2 (COL1A2) gene by the combination of two dinucleotide repeats. Gene. 1999;239(1):65\u201373.","journal-title":"Gene"},{"issue":"26","key":"643_CR89","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1093\/hmg\/10.26.3101","volume":"10","author":"O Chiba-Falek","year":"2001","unstructured":"Chiba-Falek O, Nussbaum RL. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum Mol Genet. 2001;10(26):3101\u20139.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"643_CR90","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/bbrc.1998.8972","volume":"248","author":"O Okladnova","year":"1998","unstructured":"Okladnova O et al. A promoter-associated polymorphic repeat modulates PAX-6 expression in human brain. Biochem Biophys Res Commun. 1998;248(2):402\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"643_CR91","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1161\/01.STR.30.12.2612","volume":"30","author":"DG Peters","year":"1999","unstructured":"Peters DG et al. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke. 1999;30(12):2612\u20136.","journal-title":"Stroke"},{"issue":"4","key":"643_CR92","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jmg.36.4.295","volume":"36","author":"S Searle","year":"1999","unstructured":"Searle S, Blackwell JM. Evidence for a functional repeat polymorphism in the promoter of the human NRAMP1 gene that correlates with autoimmune versus infectious disease susceptibility. J Med Genet. 1999;36(4):295\u20139.","journal-title":"J Med Genet"},{"issue":"1-2","key":"643_CR93","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0014-5793(99)00863-7","volume":"455","author":"S Shimajiri","year":"1999","unstructured":"Shimajiri S et al. Shortened microsatellite d(CA)21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene. FEBS Lett. 1999;455(1-2):70\u20134.","journal-title":"FEBS Lett"},{"issue":"10","key":"643_CR94","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1073\/pnas.0400182101","volume":"101","author":"TW Hefferon","year":"2004","unstructured":"Hefferon TW et al. A variable dinucleotide repeat in the CFTR gene contributes to phenotype diversity by forming RNA secondary structures that alter splicing. Proc Natl Acad Sci U S A. 2004;101(10):3504\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7147","key":"643_CR95","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature05977","volume":"447","author":"SM Mirkin","year":"2007","unstructured":"Mirkin SM. Expandable DNA repeats and human disease. Nature. 2007;447(7147):932\u201340.","journal-title":"Nature"},{"issue":"10","key":"643_CR96","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrg1689","volume":"6","author":"CE Pearson","year":"2005","unstructured":"Pearson CE, Nichol Edamura K, Cleary JD. Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet. 2005;6(10):729\u201342.","journal-title":"Nat Rev Genet"},{"issue":"11","key":"643_CR97","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1101\/gr.177774.114","volume":"24","author":"T Willems","year":"2014","unstructured":"Willems T et al. The landscape of human STR variation. Genome Res. 2014;24(11):1894\u2013904.","journal-title":"Genome Res"},{"issue":"7571","key":"643_CR98","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature15394","volume":"526","author":"PH Sudmant","year":"2015","unstructured":"Sudmant PH et al. An integrated map of structural variation in 2,504 human genomes. Nature. 2015;526(7571):75\u201381.","journal-title":"Nature"},{"issue":"2","key":"643_CR99","doi-asserted-by":"crossref","first-page":"e30994","DOI":"10.1371\/journal.pone.0030994","volume":"7","author":"C Linnertz","year":"2012","unstructured":"Linnertz C et al. Characterization of the poly-T variant in the TOMM40 gene in diverse populations. PLoS One. 2012;7(2):e30994.","journal-title":"PLoS One"},{"issue":"1","key":"643_CR100","first-page":"12","volume":"1","author":"WK Gottschalk","year":"2014","unstructured":"Gottschalk WK et al. The Broad Impact of TOM40 on Neurodegenerative Diseases in Aging. J Parkinson\u2019s Dis Alzheimer\u2019s Dis. 2014;1(1):12. This article summarizes the molecular and genetic evidence relating Tom40 protein and the Translocase of the Outer Mitochondrial Membrane complex to mitochondrial dysfunction and neurological disease, including LOAD and Parkinson\u2019s disease.","journal-title":"J Parkinson\u2019s Dis Alzheimer\u2019s Dis"},{"issue":"4","key":"643_CR101","doi-asserted-by":"crossref","first-page":"e62277","DOI":"10.1371\/journal.pone.0062277","volume":"8","author":"A Bender","year":"2013","unstructured":"Bender A et al. TOM40 mediates mitochondrial dysfunction induced by alpha-synuclein accumulation in Parkinson\u2019s disease. PLoS One. 2013;8(4):e62277.","journal-title":"PLoS One"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-016-0643-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-016-0643-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-016-0643-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T13:13:53Z","timestamp":1692278033000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-016-0643-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,4]]},"references-count":101,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["643"],"URL":"https:\/\/doi.org\/10.1007\/s11910-016-0643-8","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,4]]},"article-number":"48"}}